TrialJournal for immunotherapy of cancer2024

PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD/E axis in ovarian cancer.

Yu Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.